Enveric BiosciencesENVB
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 23 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings, up 12 from Q1 2026. 13 opened new positions and 1 sold out. The largest holders were Sio Capital Management, LLC ($248K), Ikarian Capital, LLC ($138K) and AdvisorShares Investments LLC ($49K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E505
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $655K |
| Exits | 1 | $2 |
All 13F filers, Q1 2026 → Q2 2026: 495,682 shares bought and 23,767 shares sold, net +471,915 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Sio Capital Management, LLC | 0.04% | New | 180,000 | $248K |
| Ikarian Capital, LLC | 0.02% | New | 100,002 | $138K |
| AdvisorShares Investments LLC | 0.01% | Add +108.7% | 35,417 | $49K |
| Renaissance Technologies | 0.00% | New | 32,058 | $44K |
| Armistice Capital, LLC | 0.00% | New | 32,000 | $44K |
| Boothbay Fund Management, LLC | 0.00% | New | 30,142 | $42K |
| XTX Topco Ltd | 0.00% | New | 18,990 | $26K |
| StoneX Group Inc. | 0.00% | New | 11,814 | $22K |
| HRT Financial LP | 0.00% | New | 15,458 | $21K |
| Vanguard Capital Management LLC | 0.00% | New | 14,912 | $21K |
| Citadel Advisors | 0.00% | New | 13,965 | $19K |
| Geode Capital Management, LLC | 0.00% | Reduce -63.3% | 11,794 | $16K |
| Virtu Financial LLC | 0.00% | New | 10,690 | $15K |
| Morgan Stanley | 0.00% | New | 10,733 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +351.9% | 4,984 | $7K |
| SBI Securities Co., Ltd. | 0.00% | Add +3124.1% | 2,676 | $4K |
| Jones Financial Companies LLLP | 0.00% | No change | 1,000 | $1K |
| UBS Group AG | 0.00% | Reduce -94.4% | 201 | $277 |
| BlackRock, Inc. | 0.00% | No change | 51 | $70 |
| Wells Fargo & Company | 0.00% | No change | 1 | $1 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| National Bank of Canada | 0.00% | No change | 1 | $1 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.